Skip to main content
. Author manuscript; available in PMC: 2016 Feb 18.
Published in final edited form as: Procedia Vaccinol. 2015;9:16–23. doi: 10.1016/j.provac.2015.05.003

Figure 4.

Figure 4

Effectiveness of Salmonella SopB4 and B5-GVNPs for immunogenicity and protection in a mouse model. A. Serum IFN-γ levels in pre- (dark gray) and post- (light gray) immunized animals; B: Bacterial load in spleen of GVNP-immunized and pathogen challenged animals, and C. Survival after pathogen challenge (PBS-solid line, NRC-1 GVNPs-dotted line and SopB5-GVNPs-dashed line)23.